{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01739049","recordId":"NCT01739049","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01739049-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct01739049.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct01739049.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2012-11-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2012-11-28","publishedAt":"2026-08-23","recordId":"NCT01739049","recordSha256":"298881e43c0b881db6a7859faf7e158c6d7bf9f4c0c02269c8ab2649856654fe","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01739049?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2014-09-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2014-09-30","publishedAt":"2026-08-23","recordId":"NCT01739049","recordSha256":"8f61fe5f1bd9e12818d6c1010a448327820b3a0f7582e0c3fa06934a90412919","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01739049?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["IPDSharing","Oversight","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2017-05-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-05-01","publishedAt":"2026-08-23","recordId":"NCT01739049","recordSha256":"6a433e3ccda0e8d9037df9d1c25d878b0142044795a551307749072597c1a62f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01739049?a=3&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"48588295e78004c66d8957a5c2c9c430150499979f5cf7e77e2e36437f981069"}}